All News

During the first year of health coverage expansion under the Affordable Care Act, many primary care providers said the number of patients they saw increased, but reported no compromise in quality of care provided, according to a study from the Kaiser Family Foundation and The Commonwealth Fund.

Although drug development is expensive, the high prices being charged for some specialty drugs, like Sovaldi, are not required to induce innovation, Len M. Nichols, PhD, wrote Monday for Morning Consult.

The authors analyzed data from 2007 to 2012 to report their findings. They say that population health efforts must go beyond screenings for chronic conditions associated with overweight and obesity and identify those at normal weight in danger of weight gain.

A study published in the New England Journal of Medicine says a CT scan following a first venous thromboebolism event may not benefit in detecting cancer.

Using mass-spectrometry—based phosphoproteomics, researchers at the Moffit Cancer Center have identified a mechanism by which BRAF/PTEN-null melanoma cells develop resistance to BRAF inhibitors.

A new report from the Kaiser Family Foundation analyzed the impact of gaining health insurance through the Affordable Care Act for low-income families.

This week 3 states received approval to set up their own state exchanges in the even the Supreme Court removes subsidies in the federally facilitated marketplace, and the deadline passed for stakeholders to respond to CMS' proposed rules for mental health parity in Medicaid managed care.

One of the most vocal physicians about the high prices of cancer drugs, Peter Bach, MD, MAPP, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, recently led the effort to create a value-based calculator to determine the true worth of cancer drugs.

In a national study that included 9 million Americans, researchers found that the hospital a patient experiencing post-surgical complications returns to for readmission has an impact on the quality of care the patient receives.

Earlier this week, the FDA heard from various stakeholders and experts from the healthcare industry on how delays in the generic approval process impact healthcare costs.

The discussion about managed care comes as lawmakers continue to ignore pleas to expand Medicaid to 191,000 uninsured residents in Missouri. A White House report released earlier this month made a case for expansion but was largely ignored by expansion opponents.

Researchers at the University of Pennsylvania correlated data from Geographic Information Systems, hospital referral regions, census data, and CDC's State Cancer Profiles, to evaluate whether geographic barriers can prevent access to gynecologic cancer care.

Newly announced fraud charges against 243 individuals involved schemes of approximately $712 million worth in false billings, according to an announcement by HHS. CMS also suspended a number of providers.

A study published in PLOS ONE found that a higher intake of dietary trans fat correlated with memory loss in men 45 years old and younger.

The first year of CMS' Independence at Home Demonstration led to both higher quality care and and saved $25 million, an average of $3070 per participating beneficiary.

Despite the increased use of breast-conserving therapy among women with early-stage breast cancer, many women continue to undergo mastectomy, according to a study from researchers at the University of Texas MD Anderson Cancer Center in Houston published in JAMA Surgery.

Scientists at Institut Pasteur in France have repurposed DPP4 inhibitors, used to treat type 2 diabetes mellitus, to boost the body's immune response to tumors.

While Republicans continue to look at dismantling President Obama's Affordable Care Act, they are also working on plans to extend subsidies temporarily to the millions of Americans who may lose the financial assistance should the Supreme Court rule in favor of the plaintiffs in King v. Burwell.

Concepts from the patient-centered medical home model can offer answers to giving the newly insured a place to find care outside of the emergency department setting.

In its proposed fiscal year 2016 funding bill, the House Appropriations Committee is looking to defund the Affordable Care Act, block additional funding for patient-centered outcomes research, and terminate the Agency for Healthcare Research and Quality.

Read how being denied new technology by my insurance company impacts me.

A report by the American Cancer Society, published in JAMA Internal Medicine, finds smoking significantly increases the risk of cancer-related death.

If the Supreme Court rules that individuals in states on the federal marketplace are ineligible for subsidies, the annual consumer premium contribution could increase $3300 in 2015, according to an analysis from Avalere Health.

The findings of inadequate access to providers and outdated information were no surprise to healthcare advocates. Many of the issues are addressed in a giant proposed rule issued by CMS in late May.

Another 2 companies that are using natural language processing and artificial intelligence in their efforts on direct-to-person health coaching.

Published in the Journal of the American Pharmacists Association, the study found a significant improvement in the blood pressure of T2DM patients who were counseled by a pharmacist.

The consensus that drug manufacturers are at fault for high prescription prices comes even though only half the respondents said they were taking medication themselves.

Although the introduction of new specialty drugs and increased investments into personal health data security, moderating forces will keep healthcare spending growth in check in 2016, according to a report from PwC's Health Research Institute.

Scientists have identified 3 gene variants of HOXD9, which can help explain the development of ovarian cancer.

A paper published in the British Medical Journal, authored by FDA staff, compares content from FDA's complete response letter for a rejected drug, with the subsequent press release by drug developers.